Target Price | €22.44 |
Price | €22.66 |
Deviation |
0.97%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target CompuGroup Medical 2026 .
The average CompuGroup Medical target price is €22.44.
This is
0.97%
register free of charge
€30.45
34.38%
register free of charge
€10.10
55.43%
register free of charge
|
|
A rating was issued by 18 analysts: 3 Analysts recommend CompuGroup Medical to buy, 8 to hold and 7 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CompuGroup Medical stock has an average upside potential 2026 of
0.97%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 1.15 | 1.20 |
2.83% | 3.81% | |
EBITDA Margin | 18.75% | 20.55% |
2.13% | 9.59% | |
Net Margin | 3.00% | 6.13% |
22.45% | 104.45% |
5 Analysts have issued a sales forecast CompuGroup Medical 2025 . The average CompuGroup Medical sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an CompuGroup Medical EBITDA forecast 2025. The average CompuGroup Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 CompuGroup Medical Analysts have issued a net profit forecast 2025. The average CompuGroup Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 0.66 | 1.42 |
25.00% | 115.15% | |
EV/Sales | 1.63 |
5 Analysts have issued a CompuGroup Medical forecast for earnings per share. The average CompuGroup Medical EPS is
This results in the following potential growth metrics and future valuations:
Current |
---|
CompuGroup Medical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.